Investing in the future of gut health.
Health Food Symmetry is a specialty health and wellness ingredient supplier with a proprietary, patented prebiotic ingredient, a $10 million Australian-owned manufacturing facility, and a decade of scientific validation behind it. We are not a startup with a concept — we are a commercially active business with traction across human health, animal health, and food manufacturing markets.
Why PhytoBiome® — why now.
The market
The global gut health sector is projected to reach USD $270 billion by 2034, driven by rising awareness of the microbiome’s role in overall health. The prebiotics market specifically is expected to more than double to USD $10.5 billion by 2030.
The global weight loss supplements market is projected to reach USD $77–100 billion by 2032–33. The global allergen-free food market is projected to reach USD $102.84 billion by 2035. The global dietary supplements market was estimated at USD $192.65 billion in 2024. The global Health and Wellness Packaged Food market was valued at USD $858 billion in 2023.
Within all of these markets, demand is shifting decisively toward clinically validated, natural, Low FODMAP, gluten-free, and whole-food-derived solutions. PhytoBiome® is the only ingredient positioned to serve all of these demands simultaneously.
The problem with existing solutions
Conventional fibre products — inulin, psyllium, wheat dextrin — are widely used but widely problematic. Rapid foregut fermentation causes bloating and discomfort, leading to poor adherence and inconsistent outcomes.
They are not true whole-plant prebiotics, they lack broad clinical validation, and they cannot carry Low FODMAP or allergen-free positioning without limitations.
HFS's solution
PhytoBiome® is the world’s first whole-plant sugarcane-derived prebiotic. Unlike isolated fibres, it delivers superior tolerability, lasting efficacy, and broad versatility across human, animal, and food sectors.
It is protected by patents, supported by 14 FSANZ notified Food-Health Relationships, certified Low FODMAP, and manufactured at scale in a GMP-certified, FDA-registered Australian facility.
Commercial traction to date.
- 425+ Australian retail locations stocked with myBiome (PhytoBiome retail products) across 5 distributors (Healthylife Pharmacy, vital.ly, Go Vita, Gut Health Store NZ, Oborne Health Supplies)
- 15 companies commercially engaged across all HFS products
- White-label partners across Australia and internationally: Healthyroo, Fertile Gut, Chief Nutrition, Real Good Food, Dessert Kitchen, IV Nutrition, Vets Love Pets, Tismor, BJP Laboratories, Envirograze, Allergywise Gluten Free, The Fix, ProVet
- International expansion underway — key partners entering the Middle East, with India and Asia planned
- Dietitian Connection partnership — extending reach to thousands of registered dietitians
- 57% of PhytoBiome for Horses sales via veterinary clinics — providing access to a potential 110,000 clinics worldwide
- Invitations to leading industry events — Dietitians Unite, Naturally Good
- Selected as industry partner in a $13M ARC grant application via RMIT University
- Engagement with First Nations owned and operated companies
How HFS generates revenue.
HFS operates a vertically integrated model, owning IP, production technology, and the GMP-certified facility. Revenue is diversified across:
- PhytoBiome 50 ingredient sales — premium B2B supply to nutraceutical and healthcare manufacturers
- PhytoBiome 100 ingredient sales — functional ingredient for food and beverage manufacturers
- myBiome retail sales — consumer brand sold through health retailers, pharmacies, and e-commerce
- White-label and co-branded product ranges — under development
- PhytoBiome for Animals — animal digestive health products via veterinary networks and retail
By owning its IP, production technology, and facility, HFS controls quality, protects margins, and scales efficiently across all revenue streams.
The HFS product ecosystem.
Together, these products address the global gut health sector, global dietary supplements market, global Health and Wellness Packaged Food market, and the animal intestinal health market — giving HFS multiple routes to revenue growth from a single proprietary ingredient platform.
PhytoBiome®
B2B prebiotic ingredient (supplements, drinks, human health)
PhytoBiome 50
B2B prebiotic ingredient (supplements, drinks, human health)
PhytoBiome 100
B2B application-ready ingredient (food and bakery manufacturing)
PhytoBiome for Animals
B2B and B2C equine and companion animal health
myBiome
myBiome — B2C retail consumer brand
Manufacturing excellence.
HFS owns and operates a $10 million, purpose-built facility in Queensland, capable of processing 1,000 tonnes annually. The facility is GMP-certified, FDA-registered, SQF and GFSI accredited, and operates a carbon offset program achieving carbon neutrality.
Expansion is currently underway, with a new pelletiser and decanter centrifuge being installed to meet growing demand across human and animal health markets.
Access the full investor document.
The HFS Investor Document contains full financial information, company structure and ownership details, competitive analysis, projections, and terms of investment. It is available to qualified investors.